Sanofi shares are listed on the Euronext Paris and are also available on the Nasdaq Global Select Market (Nasdaq) in the form of American Depositary Shares (ADS) under the symbol SNY, generally referred to as our ADR program. Between July 1, 2002 and December 31, 2018, Sanofi ADSs were listed on the New York Stock Exchange (NYSE).
JPMorgan Chase Bank acts as the depositary bank for our ADR program. Their Transfer Agent is EQ Shareowner Services in the U.S. All holders of ADSs are entitled to dividends, capital gains and to vote in our AGM.
A dedicated team is available in the U.S. to answer any questions of registered ADS holders. EQ Shareowner Services can be contacted as follows:
- Calls from the U.S: (1) 877 272 9475
- Calls from outside the U.S: (1) 651 453 2128
- Contact via email: https://www.shareowneronline.com/informational/contact-us/
- Regular correspondence:
EQ Shareowner Services
P.O. BOX 64504
St. Paul, MN 55164-0504
- Delivery of stock certificates and overnight mail:
EQ Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100
ADR Program
Sponsored level II ADR program
Sanofi stock is traded under a sponsored level II ADR program on Nasdaq, thereby offering a higher visibility in the U.S. market, more active trading and greater liquidity. Level II ADR programs must comply with the full registration and reporting requirements of the U.S. Securities and Exchange Commission (SEC) for foreign private issuers. This entails, among other things, the filing of a Form 20-F registration statement to register the listing of ADSs, including financial statements and a reconciliation of those statements to U.S. GAAP, and the filing of an annual report on Form 20-F for each year following the initial registration.
How to purchase ADRs
To purchase Sanofi ADSs, shareholders may contact a licensed stockbroker or may buy directly from our ADR depositary bank, JPMorgan Chase, through a Direct Purchase Plan with EQ Shareowner Services. The Plan provides first-time purchasers and existing shareholders of Sanofi ADSs with a convenient and economical way to invest in Sanofi. Participants can enjoy the same benefits as an investor who holds ordinary shares; they remain the registered owner of the shares and have full control over their investment decisions.
ADR Dividends
Dividend reinvestment plan
Dividends are paid by check, or they may be directly deposited into a bank account of your choice. Please let your brokerage or EQ Shareowner Services know how you would like to receive your dividend.
As a Direct Purchase Plan participant, you may elect to reinvest all or a portion of your cash dividends in additional shares. To do so, you will have to check the applicable box on the enrolment form.
Income Tax Information
ADR dividends are paid in U.S. dollars and are generally taxable, just like dividends on U.S. shares. In addition, the Republic of France, Sanofi’s home country, may withhold taxes. Depending on individual circumstances, foreign taxes withheld might be applied as a credit against U.S. taxes, or tax reclaim opportunities may be offered. For specific information, consult your tax adviser.
You may also contact Goal Group Recoveries Inc. at adroit@goalgroup.com or on +1 (212) 248-9130.
To obtain further tax information, please read our current annual report on Form 20-F filed with the Securities and Exchange Commission.
Final Information for 2024 Dividends
The Annual General Meeting 2025 approved a dividend of €3.92 per ordinary share for 2024 results.
Record date for ADRs: May 9, 2025
Payment/value date for ADRs: June 9, 2025
*Funds provided to J. P. Morgan in a foreign currency may have been converted to U.S. dollars through a foreign exchange transaction with J. P. Morgan or an affiliate. The foreign exchange rate applied to the foreign currency is determined by J.P. Morgan in its sole discretion and is either (1) the WMR Rate or (2) the JP Morgan Rate plus, in either case, up to 20 basis points.
J.P. Morgan collects fees ("Fees") from holders of depositary receipts. These Fees are described in the deposit agreement and may include, without limitation, Fees for (i) the issuance and cancellation of depositary receipts, (ii) services performed in administering the depositary receipts and (iii) distributions of cash. In most cases, J.P. Morgan reimburses the issuer for certain expenses related to the depositary receipts program and incurred by the issuer in connection with such program or shares revenue with the issuer received by J.P. Morgan from such Fees or revenues generated in connection with the Program.
History of Sanofi Annual Dividends per ADR
2024 : $2.21(1)
2023 : $2.04
2022 : $1.90
2021 : $1.75
2020 : $1.93
2019 : $1.70
2018 : $1.72
2017 : $1.79
2016 : $1.64
2015 : $1.66
2014 : $1.61
2013 : $1.91
2012 : $1.79
2011 : $1.69
2010 : $1.76
2009 : $1.47
(1) For indicative purpose only, based Foreign Exchange Rate as at April 15, 2025 (EURUSD at 1.12865)
Contact JPMorgan Chase Bank
- Phone, toll-free number: (1) 877 272 9475
- For international callers: (1) 651 453 2128
- Contact: https://www.shareowneronline.com/informational/contact-us/